Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly & Co. -0.04%370.951.1%$1218.24m
JNJJohnson & Johnson 0.29%178.510.7%$1163.40m
MRKMerck & Co., Inc. -0.61%109.450.7%$1034.88m
PFEPfizer Inc. 1.80%51.030.9%$1006.76m
ABBVAbbVie, Inc. 0.30%161.661.9%$870.82m
BMYBristol-Myers Squibb Co. 1.23%81.271.1%$769.97m
AZNAstraZeneca Plc 0.92%68.601.0%$364.15m
HZNPHorizon Therapeutics Plc 0.37%100.665.4%$307.24m
IDXXIDEXX Laboratories, Inc. 2.55%436.723.9%$237.50m
CTLTCatalent, Inc. 3.57%51.921.9%$230.70m
GSKGSK Plc 1.46%35.100.3%$196.89m
NVSNovartis AG 0.26%89.790.2%$189.45m
NVONovo Nordisk A/S 1.26%126.180.1%$174.93m
ALNYAlnylam Pharmaceuticals, Inc. 0.40%221.488.0%$162.78m
RGENRepligen Corp. 4.26%186.466.7%$139.64m

Company Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. The company was founded in 2000 and is headquartered in New York, NY.